Kristin Gerber

Kristin A. Gerber

Partner
Kristin A. Gerber
Boston
+1 617 570 1803

Kristin Gerber is a partner in the firm's Business Law Department and a member of its nationally recognized Technology and Life Sciences group, including its market leading Technology M&A practice. Ms. Gerber represents domestic and non-U.S. public and private acquirers, investors, and companies in mergers and acquisitions, dispositions, and corporate finance transactions focusing on software, hardware, biotechnology, pharmaceuticals and other technology-driven industries. Serving as her corporate clients’ general or principal outside counsel, Ms. Gerber provides strategic advice and general corporate counseling to management teams and boards while leading significant transactions on her clients’ behalf through every stage of the corporate life cycle. Ms. Gerber is heavily involved in the emerging technology and life science startup communities in Boston, regularly advising and mentoring young companies and entrepreneurs.

Ms. Gerber is a key contributor to Goodwin’s ESG & Impact practice and devotes a portion of her practice to counseling social enterprise companies, impact investors, and nonprofit companies with respect to complex corporate structures, governance and sustainability, impact metrics, financings and grant development, strategic alliances, and commercial contracts.

Representative Matters

* Denotes experience prior to joining Goodwin.

  • Represented Klaviyo in strategic partnership and financing with Shopify
  • Represented WiTricity in Series B financing led by Siemens and existing investors
  • Represented Mantra Health in $22 million Series A financing led by VMG Partners
  • Represented AptiHealth in $50 million Series B financing led by Takeda Digital Ventures and Pivotal Life Sciences
  • Represented private sustainable forestry leader in bridge financing led by consortium of investors
  • Represented Kasha Global in bridge financing led by Beyond Capital Ventures
  • Represented Amitruck in $4 million seed financing led by Better Tomorrow Ventures
  • Represented Intimately in seed financing led by Venrex and the British Fashion Council
  • Represented consortium of investors in $10.4 million bridge financing of private fintech company
  • Represented consortium led by Novastar, FMO and Global Ventures in Series B financing of TeamApt
  • Represented Klaviyo in $320 million Series D financing by consortium led by Sands Capital
  • Represented Sanergy, Inc. in a Series B-2 financing led by AXA IM and a $2.55 million bridge debt facility by consortium led by Novastar and Acumen
  • Represented private telehealth company in $2 million convertible note financing by various venture capital investors
  • Represented Stavvy in $40 million Series A financing by Morningside Technology Ventures
  • Represented Novastar Ventures in $2 million Series A financing of Turaco
  • Represented BeiGene in financing of private biotech company
  • Represented MBX Biosciences in $34.6 million Series A financing by Frasier, OrbiMed and NEA
  • Represented Komaza, Inc. in $28 million Series B financing led by AXA, FMO and Novastar
  • Represented Checkmate Pharmaceuticals in $85 million Series C financing by consortium led by Longitude and Novo
  • Represented Novastar Ventures as lead investor in $21.5 million Series C financing of mPharma Data
  • Represented syndicate of investors in $5.5 million Series A financing of STP Investment Services
  • Represented Sanergy, Inc. in $5 million debt financing by the Overseas Private Investment Corporation
  • Represented OZÉ, Inc. in $1 million convertible note financing
  • Represented Gokada Inc. in a $5.3 million Series A financing led by Rise Capital
  • Represented fintech issuer in $2 million Series Seed financing
  • Represented telehealth issuer in $2.1 million Seed financing
  • Represented proptech issuer in $2 million Seed financing
  • Represented Kyn Therapeutics in $15 million Series A-1 financing by Celgene Corporation
  • Represented Checkmate Pharmaceuticals in $90 million Series B financing by Sofinnova, venBio, F-Prime and Decheng Capital
  • Represented venture fund in $50 million investment in cell therapy company
  • Represented biotech issuer in $300 million convertible limited recourse “synthetic” note financing, $200 million Series DD financing and $75 million equipment finance facility*
  • Represented biotech issuer in $25 million Series A financing*
  • Represented biotech issuer in $23 million recapitalization and financing*
  • Represented venture fund in multiple transactions including $18 million investment in online* retailer, $7.5 million investment in merchant services provider and $5 million investment in mobile app developer*
  • Represented venture fund in multiple transactions including $110 million recapitalization of waste management issuer, $30 million investment in energy storage issuer and $20 million in a renewable energy issuer*
  • Represented venture fund in multiple transactions including $10 million investment in heating technology company, $12 million investment in insulation technology company and $20 million investment in cathode materials company*
  • Represented online gaming issuer in $18.8 million Series B financing, secondary sale of founder shares*
  • Represented wastewater treatment issuer in $12 million Series B financing, secondary sale of founder shares*
  • Represented waste management issuer in $5 million Series B, $2 million Series A-2 and $2 million Series A financings, multiple bridge debt financings, $5 million OPIC loan and $2 million grant award from major foundation*

* Denotes experience prior to joining Goodwin.

Professional Activities

Ms. Gerber is a member of the American and Boston Bar Associations, the Global Impact Investing Network, the Impact Investing Legal Working Group, and the Boston chapter of Women in Technology International. She has also served as a mentor for the MIT $100K Business Plan Competition, Cleantech Open Northeast, Boston College’s Soaring Startup Circle, and the Hult Prize Competition, and has been a guest lecturer at Boston College Law School.

Professional Experience

Prior to joining Goodwin, Ms. Gerber practiced as an associate at prominent Boston-based international law firms. She has also served as a judicial intern to the Honorable Chief Judge Joseph Bataillon in the United States District Court for the District of Nebraska and worked as a corporate auditor for the Union Pacific Corporation.

Credentials

Education

JD2008

Boston College Law School

BS in Business Admin2003

Creighton University

(magna cum laude)

Admissions

Bars

  • Massachusetts

Recognition & Awards

Ms. Gerber has been recognized in The Best Lawyers in America for Mergers and Acquisitions Law and Venture Capital Law (2023) and as a Massachusetts Super Lawyer "Rising Star" by Law & Politics and Boston magazine (2015, 2016, 2017, 2018, 2019, 2020).

Publications

Co-author, “Regulation Crowdfunding: The Long Wait Is Over, But Is Equity Crowdfunding D.O.A.?,” Venture Capital & Emerging Companies Alert, 2015

Co-author, “Takeover Considerations and Defenses,” Financing a Business in Massachusetts, MCLE, Inc., 2010